07:00 , Aug 11, 2011 |  BC Innovations  |  Distillery Therapeutics

Indication: Autoimmune disease

Indication Target/marker/ pathway Summary Licensing status Publication and contact information Autoimmune disease Autoimmune disease G protein-coupled receptor 183 (GPR183; EBI2); cholesterol 25 hydroxylase (CH25H) In vitro and mouse studies suggest antagonizing EBI2 could help treat...